REQUEST A DEMO
Total
USD $0.00
Search more companies

Pranami Drugs Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Pranami Drugs Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pranami Drugs Private Limited is a company in India, with a head office in Bharuch. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on November 15, 2002. The company’s latest financial report indicates a net sales revenue increase of 16.82% in 2025. Its’ total assets recorded a growth of 39.77%. In, 2025, the company’s net profit margin increased by 3.5%.

Legal Address
Plot No. 7209 Gidc Industrial Estate
Bharuch; Gujarat; Postal Code: 393002

Contact Details: Purchase the Pranami Drugs Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Pranami Drugs Private Limited report to view the information.
Financial Auditors:
Purchase the Pranami Drugs Private Limited report to view the information.
Incorporation Date:
November 15, 2002
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Pranami Drugs Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
16.82%
Total Operating Revenue
17.15%
Operating Profit
109.61%
EBITDA
89.82%
Net Profit/Loss for the Period
132.06%
Total Assets
39.77%
Total Equity
18.47%
Operating Profit Margin
5.24%
Net Profit Margin
3.5%
Return on Equity (ROE)
8.04%
Debt / Equity
42%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?